West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

Introduction of West Nile (WN) virus into the United States in 1999 created major human and animal health concerns. Currently, no human or veterinary vaccine is available to prevent WN viral infection, and mosquito control is the only practical strategy to combat the spread of disease. Starting with...

Полное описание

Библиографические подробности

Опубликовано в::	J Virol
Главные авторы:	Davis, Brent S., Chang, Gwong-Jen J., Cropp, Bruce, Roehrig, John T., Martin, Denise A., Mitchell, Carl J., Bowen, Richard, Bunning, Michel L.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 2001
Предметы:	Vaccines and Antiviral Agents
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114149/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11287553/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.9.4040-4047.2001
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!